UnitedHealth Group Incorporated financials

UNH CIK 0000731766

Source: EDGAR filings · Built 2026-06-02T04:17:11Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 16.07B 20.70B 25.68B 23.40B 19.89B 20.12B
EBITDA 23.32B 36.39B 36.33B 31.84B 27.07B 25.30B
Working Capital -24.32B -17.99B -20.62B -20.17B -16.53B -18.70B
Net Debt 57.93B 55.76B 40.94B 38.22B 24.63B 26.55B
Gross Margin 88.68% 88.33% 89.57% 89.60% 89.21% 88.04%
Operating Margin 4.24% 8.07% 8.71% 8.77% 8.33% 8.71%
Net Margin 2.69% 3.60% 6.02% 6.21% 6.01% 5.99%
Return on Equity (ROE) 12.05% 14.66% 23.70% 24.70% 23.03% 22.54%
Return on Assets (ROA) 3.89% 4.83% 8.18% 8.19% 8.15% 7.81%
Current Ratio 0.79× 0.83× 0.79× 0.77× 0.79× 0.74×
Debt-to-Equity 0.82× 0.82× 0.70× 0.76× 0.61× 0.64×
Effective Tax Rate 12.86% 24.06% 20.50% 21.65% 20.52% 23.98%
Cash Conversion Ratio 1.63× 1.68× 1.30× 1.30× 1.29× 1.44×
Accruals Ratio -0.02× -0.03× -0.02× -0.02× -0.02× -0.03×
SBC % of Revenue 0.22% 0.25% 0.28% 0.29% 0.28% 0.26%
CapEx Coverage 5.44× 6.92× 8.58× 9.35× 9.10× 10.81×
Free Cash Flow Per Share $17.65 $22.29 $27.38 $24.64 $20.80 $20.94

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 24.95× 32.62× 22.07× 25.03× 27.77× 21.88×
P/FCF 18.71× 22.70× 19.23× 21.52× 24.14× 16.75×
FCF Yield 5.35% 4.41% 5.20% 4.65% 4.14% 5.97%
EV / EBITDA 15.31× 14.25× 14.52× 16.76× 18.36× 14.16×
P/S 0.67× 1.16× 1.31× 1.53× 1.64× 1.29×
P/B 2.99× 4.71× 5.15× 6.08× 6.30× 4.86×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 447.57B 400.28B 371.62B 324.16B 287.60B 257.14B
Cost of Goods and Services Sold 50.66B 46.69B 38.77B 33.70B 31.03B 30.75B
Selling, General and Administrative Expense 59.59B 53.01B 54.63B 47.78B 42.58B 41.70B
Operating Income (Loss) 18.96B 32.29B 32.36B 28.43B 23.97B 22.41B
Income Tax Expense (Benefit) 1.89B 4.83B 5.97B 5.70B 4.58B 4.97B
Net Income (Loss) Attributable to Parent 12.06B 14.40B 22.38B 20.12B 17.29B 15.40B
Earnings Per Share, Basic $13.28 $15.64 $24.12 $21.47 $18.33 $16.23
Weighted Average Number of Shares Outstanding, Basic 908.00M 921.00M 928.00M 937.00M 943.00M 949.00M
Earnings Per Share, Diluted $13.23 $15.51 $23.86 $21.18 $18.08 $16.03
Weighted Average Number of Shares Outstanding, Diluted 911.00M 929.00M 938.00M 950.00M 956.00M 961.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 24.36B 25.31B 25.43B 23.36B 21.38B 16.92B
Assets, Current 90.58B 85.78B 78.44B 69.07B 61.76B 53.72B
Assets 309.58B 298.28B 273.72B 245.71B 212.21B 197.29B
Liabilities, Current 114.90B 103.77B 99.05B 89.24B 78.29B 72.42B
Long-term Debt, Excluding Current Maturities 72.32B 72.36B 58.26B 54.51B 42.38B 38.65B
Liabilities 207.88B 195.69B 174.80B 159.36B 135.73B 126.75B
Common Stock, Shares, Outstanding 906.00M 915.00M 924.00M 934.00M 941.00M 946.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 19.70B 24.20B 29.07B 26.21B 22.34B 22.17B
Payments to Acquire Property, Plant, and Equipment 3.62B 3.50B 3.39B 2.80B 2.45B 2.05B
Net Cash Provided by (Used in) Investing Activities -8.69B -20.53B -15.57B -28.48B -10.37B -12.53B
Payments for Repurchase of Common Stock 5.54B 9.00B 8.00B 7.00B 5.00B 4.25B
Net Cash Provided by (Used in) Financing Activities -11.64B -3.51B -11.53B 4.23B -7.46B -3.59B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (UNH CIK 0000731766), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

LGCY

LEGACY EDUCATION INC.

SUNS

SUNRISE REALTY TRUST, INC.

CHH

CHOICE HOTELS INTERNATIONAL INC /DE